TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7572698

Group type: EXPERIMENTAL
Intervention: AHA diet + weight loss (AHA + WL)
Number of subjects: 42

Group type: COMPARATOR
Intervention: AHA diet + weight maintenance (AHA + WM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 3-month AHA diet
Number of subjects: 42
Study: 1951552

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 50
Study: 6816132

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31634154

Group type: EXPERIMENTAL
Intervention: AHEU
Number of subjects: 933

Group type: COMPARATOR
Intervention: HUU
Number of subjects: 933
Study: 31267965

Group type: EXPERIMENTAL
Intervention: Quizartinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salvage chemotherapy
Number of subjects: 0
Study: 28254171

Group type: COMPARATOR
Intervention: Health Canada's food guide (control, n = 486)
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Dietary advice consistent with both Dietary Approaches to Stop Hypertension (DASH) and dietary portfolio principles (n = 145)
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Weekly food provision reflecting this advice (n = 148)
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Food delivery plus advice (n = 140)
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: All groups (test and control)
Number of subjects: 919
Study: 25886941

Group type: EXPERIMENTAL
Intervention: 6-week online self-help program aimed at reducing suicidal thoughts
Number of subjects: 570

Group type: COMPARATOR
Intervention: 6-week attention-matched control program
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 6-week online self-help program
Number of subjects: 570
Study: 23195393

Group type: EXPERIMENTAL
Intervention: Melatonin (5mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 21075681

Group type: EXPERIMENTAL
Intervention: Cyproheptadine hydrochloride (serotonin receptor 5-HT2 antagonist)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 19548855

Group type: EXPERIMENTAL
Intervention: Sustained-release fampridine (fampridine SR)
Number of subjects: 0
Study: 17095643

Group type: EXPERIMENTAL
Intervention: 10 g bovine colostrum protein concentrate (CPC)/day
Number of subjects: 29
Study: 14507547

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy for bulimia nervosa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11054194

Group type: EXPERIMENTAL
Intervention: Glucagon 0.03 mg/kg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 46
Study: 8736249

Group type: EXPERIMENTAL
Intervention: Short course in pre‐ and post‐test counselling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual curriculum (Control)
Number of subjects: 0
Study: 1443818

Group type: EXPERIMENTAL
Intervention: 2 mg.kg‐1 of ketamine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (5 ml of normal saline)
Number of subjects: 26
Study: 2578701

Group type: EXPERIMENTAL
Intervention: High phosphatidylcholine meal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lecithin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31657615

Group type: EXPERIMENTAL
Intervention: Probiotic supplement containing two genera and five species of bacteria
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 28278361

Group type: EXPERIMENTAL
Intervention: Individualised nurse-led home exercise prescription and behavioural support for 12 weeks
Number of subjects: 113

Group type: COMPARATOR
Intervention: In-centre group exercise training weekly for 6 weeks
Number of subjects: 113
Study: 25473823

Group type: EXPERIMENTAL
Intervention: Intermittent lower-body negative pressure (LBNP) therapy for 60 min daily after exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no LBNP therapy)
Number of subjects: 24
Study: 24350408

Group type: EXPERIMENTAL
Intervention: Bolus injection of 1 g every eight hours (q8h) for 24 hours
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3-hour infusion of 1 g q8h for 24 hours
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3-hour infusion of 2 g q8h for 24 hours
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3-hour infusion regimens
Number of subjects: 9
Study: 20361330

Group type: EXPERIMENTAL
Intervention: Active disease patients
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Inactive disease patients
Number of subjects: 41

Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 41
Study: 19604597

Group type: EXPERIMENTAL
Intervention: Extended information regarding new influenza drugs
Number of subjects: 534

Group type: COMPARATOR
Intervention: Limited information regarding new influenza drugs
Number of subjects: 534
Study: 17245718

Group type: EXPERIMENTAL
Intervention: IFN alpha‐2a treatment
Number of subjects: 18
Study: 14982567

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg ml(‐1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 63
Study: 11273575

Group type: EXPERIMENTAL
Intervention: Natural work-life intervention allowing up to five days of self-administered sick leave with full financial compensation up to four times a year.
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 265
Study: 11324075

Group type: EXPERIMENTAL
Intervention: Marital conflict
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Divorce
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marital problems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coparenting, marital happiness, and the institution of marriage
Number of subjects: 0
Study: 7697245

Group type: EXPERIMENTAL
Intervention: Capsaicin (10(‐9) to 3 x 10(‐5) mmol)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Colchicine
Number of subjects: 16
Study: 2575977

Group type: EXPERIMENTAL
Intervention: Epanolol 200mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epanolol (100mg, 200mg, 300mg, 400mg)
Number of subjects: 0
Study: 330885

Group type: EXPERIMENTAL
Intervention: Lymphocyte-mediated cytotoxicity against T24 cells
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control melanoma cell line (H894)
Number of subjects: 53
Study: 31064970

Group type: EXPERIMENTAL
Intervention: Web-based KTAS learning program (280 minutes over five weeks, including 40 minutes of orientation and four 60-minute sessions)
Number of subjects: 59
Study: 28763712

Group type: EXPERIMENTAL
Intervention: Genium prosthesis
Number of subjects: 20

Group type: COMPARATOR
Intervention: C-Leg prosthesis
Number of subjects: 20
Study: 26268104

Group type: EXPERIMENTAL
Intervention: Nutritional supplement with micronutrients and plant extracts
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 23535700

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 141

Group type: COMPARATOR
Intervention: Labetalol
Number of subjects: 141
Study: 21572981

Group type: EXPERIMENTAL
Intervention: Single dose oral ivermectin (200 microgram/kilogram body weight)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Double doses of oral ivermectin (given 2 weeks apart)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 7-day course of oral albendazole (800 mg daily)
Number of subjects: 90
Study: 19880462

Group type: EXPERIMENTAL
Intervention: Second-generation antidepressants (various types)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Policies that improve access to care (e.g., encouraging primary care treatment of depression)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Policies that promote treatment adherence (e.g., pay-for-performance initiatives)
Number of subjects: 0
Study: 16214831

Group type: EXPERIMENTAL
Intervention: Ablation and antiarrhythmic drug therapy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Antiarrhythmic drug therapy alone (control group)
Number of subjects: 137
Study: 12525441

Group type: EXPERIMENTAL
Intervention: Flutamide (125 mg/day) + Metformin (1275 mg/day) + Low-dose Oral Contraceptive (ethinyl estradiol 20 microg + gestodene 75 microg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Flutamide (125 mg/day) + Metformin (1275 mg/day)
Number of subjects: 24
Study: 10592723

Group type: EXPERIMENTAL
Intervention: Patients with stable angina pectoris (both with and without previous myocardial infarction)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Patients without previous myocardial infarction
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Patients with previous myocardial infarction
Number of subjects: 156

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 156
Study: 8948238

Group type: EXPERIMENTAL
Intervention: 3% carbamide peroxide (CP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3% CP and 10% CP
Number of subjects: 0
Study: 1915214

Group type: EXPERIMENTAL
Intervention: Dieting to lose weight
Number of subjects: 4647

Group type: EXPERIMENTAL
Intervention: Participation in organized weight-loss programs
Number of subjects: 4647

Group type: COMPARATOR
Intervention: Dieters
Number of subjects: 4647
Study: 6755046

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Azathioprine and steroids (control)
Number of subjects: 232
Study: 2415436

Group type: EXPERIMENTAL
Intervention: Short course of adenine arabinoside‐5'‐monophosphate (4 weeks)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon (12 weeks)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Long course of adenine arabinoside‐5'‐monophosphate (7 to 8 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 29714275

Group type: EXPERIMENTAL
Intervention: Proposed strategy to solve stagnation problem of traditional PSO algorithm for phase diversity (PD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Redistributing mechanism with randomized Halton sequences
Number of subjects: 0
Study: 26596971

Group type: EXPERIMENTAL
Intervention: Decitabine (DAC)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 206
Study: 24774721

Group type: EXPERIMENTAL
Intervention: Hypofractionated carbon ion radiation therapy (64 GyE in 16 fractions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypofractionated proton radiation therapy (64 GyE in 16 fractions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions (carbon ion and proton therapy)
Number of subjects: 0
Study: 22656399

Group type: EXPERIMENTAL
Intervention: 2.5 mm incision with one-piece intraocular lens (Acrysof SA60AT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 3.5 mm incision with three-piece intraocular lens (Tecnis Z9000)
Number of subjects: 18
Study: 20052524

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18928998

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (1000 mg or less intravenously over 15 minutes, repeated weekly to a maximum of 2500 mg)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Ferrous sulfate (325 mg orally thrice daily for 6 weeks)
Number of subjects: 291
Study: 16032522

Group type: EXPERIMENTAL
Intervention: Increased sulphur dioxide concentrations and total suspended atmospheric particles concentrations during the air pollution episode
Number of subjects: 0
Study: 12688447

Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 300 mg of caffeine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 100 mg of caffeine
Number of subjects: 62
Study: 10687932

Group type: EXPERIMENTAL
Intervention: H.E.L.P.-apheresis
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard treatment (prednisolone, dextranes, pentoxifyllin)
Number of subjects: 27
Study: 8724089

Group type: EXPERIMENTAL
Intervention: Lumbar discectomy
Number of subjects: 126

Group type: COMPARATOR
Intervention: Medical therapy (control)
Number of subjects: 126
Study: 1925896

Group type: EXPERIMENTAL
Intervention: Estrogen receptor positive (ER+) tumors (greater than or equal to 3 femtomoles per milligram cytosol of protein)
Number of subjects: 1392

Group type: COMPARATOR
Intervention: Estrogen receptor negative (ER-) tumors (less than 3 femtomoles per milligram cytosol protein)
Number of subjects: 1392

Group type: EXPERIMENTAL
Intervention: Patients with ER+ tumors
Number of subjects: 1392
Study: 6918220

Group type: EXPERIMENTAL
Intervention: Mevinolin 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mevinolin 15 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mevinolin 50 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30793994

Group type: EXPERIMENTAL
Intervention: Caffeine intervention: 216 mg caffeine from coffee beverages made from 6 g pure coffee beans (36 mg of caffeine per gram).
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control: 200 mg lactose without caffeine.
Number of subjects: 40
Study: 29395870

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (ICBT)
Number of subjects: 740

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 740
Study: 27422890

Group type: EXPERIMENTAL
Intervention: Golimumab (GOL)
Number of subjects: 299
Study: 24611660

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 23043923

Group type: EXPERIMENTAL
Intervention: Yiqiyangxin Chinese medicine compound combined with cognitive therapy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Paroxetine combined with cognitive therapy
Number of subjects: 202
Study: 20346534

Group type: EXPERIMENTAL
Intervention: Cirrhosis Relative Wellness Index (developed using desirability functions)
Number of subjects: 109
Study: 18444446

Group type: EXPERIMENTAL
Intervention: Sufentanil + Haloperidol 3 mg/h infusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sufentanil + Propofol 25 microg/kg/min infusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sufentanil + Midazolam 0.04 mg/kg/h infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil infusion (Control group)
Number of subjects: 60
Study: 16129367

Group type: EXPERIMENTAL
Intervention: Severe neutropenia (grade 3-4)
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: Mild neutropenia (grade 1-2)
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: No neutropenia (grade 0)
Number of subjects: 1265
Study: 11929373

Group type: EXPERIMENTAL
Intervention: MDI
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: MDI with holding chamber (MDI-HC)
Number of subjects: 208

Group type: COMPARATOR
Intervention: PFM
Number of subjects: 208
Study: 11066617

Group type: EXPERIMENTAL
Intervention: Mailing First Look booklet
Number of subjects: 6923

Group type: COMPARATOR
Intervention: Control group (no booklet mailed)
Number of subjects: 6923
Study: 8739145

Group type: EXPERIMENTAL
Intervention: Palatal plate therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 1681918

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g intravenously at the time of skin incision (Group I, n = 112)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Cefuroxime 1.5 g intravenously at the time of skin incision, followed by a second dose eight hours later (Group II, n = 107)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (Group I)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Cefuroxime (Group II)
Number of subjects: 219
Study: 6627831

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ibuprofen and Acetaminophen (concurrent use)
Number of subjects: 20
Study: 31418329

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) training for 8 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 34
Study: 30024241

Group type: EXPERIMENTAL
Intervention: Compromise and asymmetric-dominance decoys
Number of subjects: 6312

Group type: EXPERIMENTAL
Intervention: Balanced exposure to candidates' warmth and competence information
Number of subjects: 6312
Study: 27774917

Group type: EXPERIMENTAL
Intervention: High dietary calcium meal (HDCM; 547 mg DC)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High supplemental calcium meal (HSCM; 500 mg SC-calcium carbonate)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low calcium meal (LCM; 42 mg DC)
Number of subjects: 16
Study: 25227981

Group type: EXPERIMENTAL
Intervention: Midlife dietary vitamin D intake (quartiles Q4 vs. Q1)
Number of subjects: 1990
Study: 22844391

Group type: EXPERIMENTAL
Intervention: Single-item multimedia screening instrument (VS-CMD)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Text-based agoraphobia items of the PDSS-SR
Number of subjects: 85
Study: 20196711

Group type: EXPERIMENTAL
Intervention: Consultation from a palliative care team in addition to usual ICU end-of-life care
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual ICU end-of-life care without palliative care team consultation
Number of subjects: 20
Study: 17933742

Group type: EXPERIMENTAL
Intervention: Self-affirmation induced prior to message reception
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-affirmation induced after message reception
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of timing of self-affirmation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-affirmation
Number of subjects: 0
Study: 15613414

Group type: EXPERIMENTAL
Intervention: Testosterone patches (300 mcg testosterone over 24 hours, applied twice weekly)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Testosterone patches
Number of subjects: 52
Study: 12215589

Group type: EXPERIMENTAL
Intervention: Echovist-300
Number of subjects: 81

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 81
Study: 9527734

Group type: EXPERIMENTAL
Intervention: Propofol 30 mg x h(‐1)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Fat emulsion (Intralipid) 3 ml x h(‐1)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study: 7658178

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 0
Study: 2711539

Group type: EXPERIMENTAL
Intervention: Vibration (20 Hz, 20 m/s2 RMS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No vibration
Number of subjects: 8
Study: 1148032

Group type: EXPERIMENTAL
Intervention: Halofenate (MK-185, 1 g/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Clofibrate (2 g/day)
Number of subjects: 23
Study: 31084994

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 326

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 25866134

Group type: EXPERIMENTAL
Intervention: Patency group (n = 32)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Nonpatency group (n = 33)
Number of subjects: 68
Study: 24094562

Group type: EXPERIMENTAL
Intervention: PLMA with Coopdech BB (group PLMA‐BB, n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ETT with Coopdech BB (group ETT‐BB, n=50)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PLMA with Coopdech BB
Number of subjects: 100
Study: 24122944

Group type: EXPERIMENTAL
Intervention: MK-7288 (10, 20 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 20090299

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis carrier screening
Number of subjects: 241
Study: 18727657

Group type: EXPERIMENTAL
Intervention: SRP+MTZ+AMX (metronidazole 400 mg 3 x per day and amoxicillin 500 mg 3 x per day for 14 days)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: SRP+MTZ (metronidazole 400 mg 3 x per day for 14 days)
Number of subjects: 43

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 43
Study: 16753310

Group type: EXPERIMENTAL
Intervention: Doxycycline treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 14583903

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention (monthly consultations for 6 months)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention and Usual care
Number of subjects: 152
Study: 10963636

Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin
Number of subjects: 208

Group type: COMPARATOR
Intervention: Paclitaxel and cisplatin
Number of subjects: 208
Study: 8765459

Group type: EXPERIMENTAL
Intervention: Topical Aloe vera extract 0.5% in a hydrophilic cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 7933528

Group type: EXPERIMENTAL
Intervention: L-627 (biapenem) at a dose of 10 mg/kg and 12 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: L-627 (biapenem)
Number of subjects: 14
Study: 3138879

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28175295

Group type: EXPERIMENTAL
Intervention: Vernakalant (3 mg/kg followed by 2 mg/kg if necessary)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ibutilide (1 mg followed by another 1 mg if necessary)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vernakalant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ibutilide
Number of subjects: 100
Study: 27253482

Group type: EXPERIMENTAL
Intervention: 1000 IU of vitamin D3 and 1500 mg of calcium daily; 50,000 IU of ergocalciferol (vitamin D2) weekly for vitamin D deficient and insufficient patients until levels normalized or fractures healed.
Number of subjects: 201
Study: 23466269

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243